☰

Timothy R. Petersen, Ph.D. - Publications

Affiliations: 
2010 Anthropology University of New Mexico, Albuquerque, NM, United States 
Area:
Physical Anthropology, Systematic Biology
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Pearson OM, Petersen TR, Sparacello VS, Daneshvari SR, Grine FE. Activity, body shape, and cross-sectional geometry of the femur and tibia Reconstructing Mobility: Environmental, Behavioral, and Morphological Determinants. 133-151. DOI: 10.1007/978-1-4899-7460-0-8  0.55
2009 Petersen T, Andreotti CF, Chelminski I, Young D, Zimmerman M. Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder? Psychiatry Research. 169: 7-11. PMID 19596155 DOI: 10.1016/J.Psychres.2008.10.036  0.358
2008 Pedrelli P, Feldman GC, Vorono S, Fava M, Petersen T. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression. Psychiatry Research. 161: 302-8. PMID 18976817 DOI: 10.1016/J.Psychres.2007.08.004  0.351
2007 Papakostas GI, Petersen T, Homberger CH, Green CH, Smith J, Alpert JE, Fava M. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 5-8. PMID 17453655 DOI: 10.1080/10401230601163451  0.349
2007 Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Nicholas L, Fava M. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Annals of Family Medicine. 5: 126-34. PMID 17389536 DOI: 10.1370/Afm.641  0.34
2007 Papakostas GI, Petersen T, Sklarsky KG, Nierenberg AA, Alpert JE, Fava M. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Research. 149: 195-200. PMID 17157390 DOI: 10.1016/J.Psychres.2006.03.014  0.343
2006 Petersen T, Iosifescu DV, Papakostas GI, Shear DL, Fava M. Clinical characteristics of depressed patients with comorbid diabetes mellitus. International Clinical Psychopharmacology. 21: 43-47. PMID 16317316 DOI: 10.1097/01.Yic.0000182122.36425.B1  0.322
2005 Iosifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE, Nierenberg AA, Fava M. Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosomatic Medicine. 67: 703-6. PMID 16204427 DOI: 10.1097/01.Psy.0000170338.75346.D0  0.357
2005 Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Comprehensive Psychiatry. 46: 266-71. PMID 16175757 DOI: 10.1016/J.Comppsych.2004.10.005  0.326
2005 Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatric Services (Washington, D.C.). 56: 995-1004. PMID 16088018 DOI: 10.1176/Appi.Ps.56.8.995  0.362
2005 Petersen T, Papakostas GI, Posternak MA, Kant A, Guyker WM, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M. Empirical testing of two models for staging antidepressant treatment resistance. Journal of Clinical Psychopharmacology. 25: 336-341. PMID 16012276 DOI: 10.1097/01.Jcp.0000169036.40755.16  0.338
2005 Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 523-8. PMID 15877935 DOI: 10.1017/S1461145705005195  0.344
2005 Gaynes BN, Rush AJ, Trivedi M, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Schneider RK, Castro DB, Golden RN. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. General Hospital Psychiatry. 27: 87-96. PMID 15763119 DOI: 10.1016/J.Genhosppsych.2004.10.003  0.378
2005 Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. Erratum: The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine (International Journal of Neuropsychopharmacology (2005) DOI: 10.1017/S1461145705005195) The International Journal of Neuropsychopharmacology. 8. DOI: 10.1017/S1461145705005742  0.306
2004 Papakostas GI, Petersen T, Denninger JW, Tossani E, Pava JA, Alpert JE, Nierenberg AA, Fava M. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. Journal of Clinical Psychopharmacology. 24: 507-11. PMID 15349006 DOI: 10.1097/01.Jcp.0000138761.85363.D5  0.354
2004 Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. The Journal of Clinical Psychiatry. 65: 1096-8. PMID 15323595 DOI: 10.4088/Jcp.V65N0811  0.321
2004 Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. The Journal of Clinical Psychiatry. 65: 1090-5. PMID 15323594 DOI: 10.4088/Jcp.V65N0810  0.357
2004 Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychological Medicine. 34: 555-61. PMID 15259840 DOI: 10.1017/S0033291703001028  0.326
2004 Papakostas GI, Iosifescu DV, Petersen T, Hamill SK, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. Journal of Clinical Psychopharmacology. 24: 467-9. PMID 15232350 DOI: 10.1097/01.Jcp.0000132343.58584.1D  0.318
2004 Petersen T, Papakostas GI, Mahal Y, Guyker WM, Beaumont EC, Alpert JE, Fava M, Nierenberg AA. Psychosocial functioning in patients with treatment resistant depression. European Psychiatry : the Journal of the Association of European Psychiatrists. 19: 196-201. PMID 15196600 DOI: 10.1016/J.Eurpsy.2003.11.006  0.362
2004 Papakostas GI, Petersen T, Hughes ME, Nierenberg AA, Alpert JE, Fava M. Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. Psychiatry Research. 126: 287-90. PMID 15157754 DOI: 10.1016/J.Psychres.2004.02.007  0.358
2004 Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. General Hospital Psychiatry. 26: 13-7. PMID 14757297 DOI: 10.1016/J.Genhosppsych.2003.07.004  0.308
2004 Friedman ES, Thase ME, Kornblith SJ, Wisniewski SR, Briggs MM, Rush AJ, Carmin C, Hollon SD, Petersen T, Veenstra G. The implementation of cognitive therapy in STAR*D Cognitive Therapy and Research. 28: 819-833. DOI: 10.1007/S10608-004-0668-1  0.307
2003 Papakostas GI, Petersen T, Denninger JW, Montoya HD, Nierenberg AA, Alpert JE, Fava M. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 15: 187-92. PMID 14971864 DOI: 10.1023/B:Acli.0000008172.20590.22  0.341
2003 Papakostas GI, Petersen T, Worthington JJ, Roffi PA, Alpert JE, Fava M, Nierenberg AA. A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed. International Clinical Psychopharmacology. 18: 293-6. PMID 12920390 DOI: 10.1097/00004850-200309000-00006  0.353
2003 Papakostas GI, Petersen T, Pava J, Masson E, Worthington JJ, Alpert JE, Fava M, Nierenberg AA. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome. The Journal of Nervous and Mental Disease. 191: 444-9. PMID 12891091 DOI: 10.1097/01.Nmd.0000081591.46444.97  0.355
2003 Papakostas GI, Petersen T, Iosifescu DV, Roffi PA, Alpert JE, Rosenbaum JF, Fava M, Nierenberg AA. Axis III disorders in treatment-resistant major depressive disorder. Psychiatry Research. 118: 183-8. PMID 12798983 DOI: 10.1016/S0165-1781(03)00067-2  0.35
2003 Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M, Nierenberg AA. Serum cholesterol in treatment-resistant depression. Neuropsychobiology. 47: 146-51. PMID 12759558 DOI: 10.1159/000070584  0.358
2003 Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE, Nierenberg AA, Fava M. Somatic symptoms in treatment-resistant depression. Psychiatry Research. 118: 39-45. PMID 12759160 DOI: 10.1016/S0165-1781(03)00063-5  0.308
2003 Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M. Nortriptyline for treatment-resistant depression. The Journal of Clinical Psychiatry. 64: 35-9. PMID 12590621 DOI: 10.4088/Jcp.V64N0108  0.358
2003 Nierenberg AA, Papakostas GI, Petersen T, Montoya HD, Worthington JJ, Tedlow J, Alpert JE, Fava M. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. Journal of Clinical Psychopharmacology. 23: 92-5. PMID 12544380 DOI: 10.1097/00004714-200302000-00013  0.37
2003 Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA. Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. Comprehensive Psychiatry. 44: 44-50. PMID 12524635 DOI: 10.1053/Comp.2003.50012  0.331
2003 Fava M, Papakostas G, Petersen T, Mahal Y, Quitkin F, Stewart J, McGrath P. Switching to Bupropion in Fluoxetine-Resistant Major Depressive Disorder Annals of Clinical Psychiatry. 15: 17-22. DOI: 10.1023/A:1023224525400  0.367
2002 Petersen T, Hughes M, Papakostas GI, Kant A, Fava M, Rosenbaum JF, Nierenberg AA. Treatment-resistant depression and Axis II comorbidity Psychotherapy and Psychosomatics. 71: 269-274. PMID 12207107 DOI: 10.1159/000064808  0.344
2002 Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. A survey of prescribing practices in the treatment of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 177-87. PMID 11853110 DOI: 10.1016/S0278-5846(01)00250-0  0.302
2002 Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Research. 109: 9-16. PMID 11850046 DOI: 10.1016/S0165-1781(01)00359-6  0.365
2002 Sonawalla S, Neault N, Hughes M, Petersen T, Dording C, Yeung A, Fava M. Depressive disorders among minority and nonminority college students European Neuropsychopharmacology. 12: 247. DOI: 10.1016/S0924-977X(02)80314-5  0.302
2001 Petersen T, Bottonari K, Alpert JE, Fava M, Nierenberg AA. Use of the five-factory inventory in characterizing patients with major depressive disorder Comprehensive Psychiatry. 42: 488-493. PMID 11704941 DOI: 10.1053/Comp.2001.27897  0.376
2001 Petersen T, Gordon JA, Kant A, Fava M, Rosenbaum JF, Nierenberg AA. Treatment resistant depression and axis I co-morbidity. Psychological Medicine. 31: 1223-9. PMID 11681548 DOI: 10.1017/S0033291701004305  0.364
Show low-probability matches.